Calla Lily Clinical Care and Merck Announce Strategic Collaboration to Advance Intravaginal Drug Delivery Platform Calla Lily Clinical Care, a women’s health-focused medical technology company, and Merck, a leading science and technology company, have entered a strategic collaboration to support…
New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) Medical Device…
ZCG-Backed Unimed Acquires Regenboog Shipping Pharmacy Universal Maritime Solutions a leading global provider of medical and compliance solutions to the maritime industry, today announced the acquisition of Regenboog Shipping Pharmacy, a Netherlands-based distributor of pharmaceutical products and medical devices serving the maritime sector.…
bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board bioAffinity Technologies, Inc. a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced new appointments to its Medical and Scientific Advisory…
NextPoint Therapeutics Announces Clinical Entry of NPX372, a First-in-Class B7-H7–Targeted T Cell Engager to Treat Solid Tumors NextPoint Therapeutics, a clinical-stage biotechnology company developing a new world of precision therapeutics through its leading scientific work on the novel B7-H7 axis, today announced…
Median Technologies Receives FDA 510(k) Clearance for eyonis® LCS, the First AI Tech-Based Detection and Diagnosis Device for Lung Cancer Screening Median Technologies developer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early…
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1 Takeda today announced that the U.S. Food and Drug Administration (FDA) accepted its New…
Muse Brings Deep Sleep Stimulation Home Muse today announced Deep Sleep Boost (DSB), a new sleep feature designed to help users sustain deeper, more stable slow-wave sleep. Powered by Muse S Athena, Deep Sleep Boost delivers targeted slow-wave sleep support…
Galux Raises $29M Series B to Advance AI-Driven Protein Design for Drug Discovery Galux, a South Korea-based biotech pioneering AI-driven protein therapeutics design, today announced the successful completion of a $29 million (KRW 42 billion) Series B financing. With this…
athenahealth and b.well Introduce Patient-Controlled Digital Health Data Sharing at the Point of Care athenahealth and b.well Connected Health today announced a new point-of-care workflow allowing patients to securely share their health information digitally during intake—without paper forms, faxes, or multiple portal logins.…